Skip to main content
. 2011 Dec 22;13(6):R213. doi: 10.1186/ar3546

Table 4.

Clinical response of the 13 patients with increased ANA titer after IFX

ANA titer EULAR response

Before After
1 < 40 80 Good
2 < 40 80 No
3 < 40 640 No
4 < 40 640 No
5 40 160 No
6 40 160 No
7 40 160 Moderate
8 40 320 No
9 40 320 No
10 40 1,280 No
11 80 640 Moderate
12 160 640 No
13 320 1,280 No

ANAs, antinuclear antibodies; IFX, infliximab.